Predictive value of combined serum IL-6 with UREA on severity of neonatal pneumonia: an observational study

Ci Li, Zhe Xu, Hongqi Sun, Yang Liu, Manjie Nie, Weihua Gong, Junmei Yang, Tiewei LiJournal of Laboratory Medicine 2023 · DOI

Introduction

Neonatal pneumonia remains a significant contributor to infant mortality worldwide. Identifying infants at high risk for severe disease is challenging because newborns often present with subtle or inconsistent clinical signs. While biomarkers like C-reactive protein (CRP) are commonly used, they often lag behind the inflammatory process. This study investigates whether combining Interleukin-6 (IL-6), an early inflammatory marker, with Urea Nitrogen (UREA), a marker of metabolic stress and renal function, can provide a more accurate "early warning system" for disease severity.

Methods and Patient Population

The researchers conducted a retrospective, cross-sectional analysis of 105 neonates (aged 1–28 days) hospitalized at the Children’s Hospital Affiliated to Zhengzhou University between 2019 and 2022. Patients were categorized into "mild to moderate" (n=76) and "severe" (n=29) pneumonia groups based on clinical guidelines.

Laboratory parameters, including IL-6 (measured via electrochemiluminescence) and UREA (measured via automatic biochemistry analyzer), were collected upon admission. The study excluded infants with confounding conditions such as congenital heart or kidney disease to ensure the biomarkers specifically reflected pneumonia-related stress.

Table 1: Clinical and laboratory characteristics of neonates with mild to moderate vs. severe pneumonia.

Key Results

The analysis revealed significant differences between the two groups. Both serum IL-6 and UREA levels were markedly higher in the severe pneumonia group compared to the mild-to-moderate group (p < 0.05). Multivariate logistic regression identified IL-6 (OR=1.002) and UREA (OR=1.420) as independent risk factors for pneumonia severity.

The primary finding was the superior predictive performance of the combined model. Receiver Operating Characteristic (ROC) curve analysis showed that the combination of IL-6 and UREA achieved an Area Under the Curve (AUC) of 0.809, significantly outperforming IL-6 (AUC=0.683) or UREA (AUC=0.695) alone.

Figure 1: ROC curve analysis comparing the predictive value of IL-6, UREA, and their combination for neonatal pneumonia severity.

Optimal cut-off points were determined to be 42.24 pg/mL for IL-6 and 4.05 mmol/L for UREA. Crossing these thresholds, particularly in combination, strongly suggests the presence of severe disease.

Discussion and Clinical Implications

The study supports a "crosstalk" hypothesis between lung inflammation and systemic metabolic stress. Severe pneumonia triggers dehydration and increased protein catabolism, leading to elevated UREA levels even before overt renal failure occurs. Meanwhile, IL-6 acts as a rapid responder in the inflammatory cascade, appearing earlier than other acute-phase proteins.

By combining these two independent markers, clinicians gain a more holistic view of the infant's physiological state. This "biomarker cocktail" offers a sensitive and specific tool for identifying critical cases early, potentially allowing for more aggressive interventions and improved clinical outcomes.

Limitations and Future Work

While promising, the study is limited by its relatively small sample size (N=105) and its single-center, retrospective design. Furthermore, biomarkers were only measured at admission; longitudinal tracking might offer even greater predictive accuracy. Future multi-center studies are needed to validate these findings across diverse populations and explore the long-term outcomes of infants identified through this model.

Summary updated

Abstract

Abstract Objectives IL-6 is an inflammatory marker and urea nitrogen (UREA) is a common indicator of glomerular filtration function. Their combined detection has predictive value for the severity of neonatal pneumonia. Methods We performed a cross-sectional analysis of the clinical and laboratory data, collected from 105 neonatal patients (including 76 mild to moderate pneumonia patients and 29 severe pneumonia patients). Results Mann–Whitney U-test showed serum IL-6 and UREA levels were significantly increased in severe pneumonia, compared with that in mild to moderate pneumonia (p&lt;0.05). Correlation analysis showed the severity of neonatal pneumonia was positively correlated with serum IL-6 (r=0.284, p&lt;0.05) and UREA (r=0.303, p&lt;0.05) levels. Multivariate logistic regression analysis showed the increased levels of IL-6 (OR=1.002, 95 % CI 1.001–1.004) and UREA (OR=1.420, 95 % CI 1.046–1.926) were independent risk factors for the severity of neonatal pneumonia. ROC curve analysis showed that the predictive value of combined detection of serum IL-6 and UREA in the severity of neonatal pneumonia was better than that of either detection alone (area under curve [AUC] = 0.809, 95 % CI 0.711–0.894, p&lt;0.001). Conclusions Combined detection of IL-6 and UREA had a good predictive value for evaluating the severity of neonatal pneumonia.
BibTeX
@article{li2023predictive,
  author = {Ci Li and Zhe Xu and Hongqi Sun and Yang Liu and Manjie Nie and Weihua Gong and Junmei Yang and Tiewei Li},
  title = {{Predictive value of combined serum IL-6 with UREA on severity of neonatal pneumonia: an observational study}},
  journal = {Journal of Laboratory Medicine},
  year = {2023},
  doi = {10.1515/labmed-2023-0077},
}
Figure